InvestorAdvancing Malaysia's Bioeconomy through Biotechnology Investments

Center Ventures is a Taiwanese biotechnology investment firm that focuses on supporting biotech and health companies in reaching international markets. It operates as an incubator and investor across various sectors within the biotechnology industry.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Founded in 2008, 晟德(TWO:4123)Center Ventures has transitioned from a pharmaceutical company to a leading biotechnology investment and incubation platform in Taiwan. The organization aims to support promising biotech and health companies, facilitating their growth and international expansion. With a diverse portfolio that includes drug development, medical devices, and agricultural biotechnology, Center Ventures emphasizes nurturing companies with significant growth potential. The firm also runs a talent training camp to develop young professionals in the biotech industry, further contributing to the ecosystem.
The organization invests across various sectors within the biotechnology and health industries, including drug development, protein and antibody drug development, health products, agricultural biotechnology, and medical devices. Their investment strategy emphasizes nurturing companies with significant growth potential and facilitating their international expansion.
晟德 Center Ventures adds value to its portfolio companies through its extensive network, industry expertise, and resources aimed at facilitating international market entry and growth. The organization also runs a talent training camp to nurture young professionals in the biotech industry, further enhancing the ecosystem.
TWO:4123 Center Ventures focuses on early-stage investments in the biotech and healthcare sectors. They look for startups with significant growth potential and innovative solutions that can address market needs.
Founders can pitch their startups by reaching out through the official website. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
The firm specializes in biotech and healthcare investments, leveraging its extensive industry experience and resources to support startups in these sectors. Their focus on nurturing companies for international expansion sets them apart.
The firm primarily operates in the Asian market, focusing on startups based in Taiwan and other Asian countries.
While specific check sizes are not disclosed, TWO:4123 Center Ventures invests in early-stage rounds, which typically range from pre-seed to seed-plus stages.
Portfolio companies benefit from access to resources, mentorship, and potential partnerships that can enhance their growth and facilitate international market entry.
Superscout Pro
Is this page right?Reviewed · How the research works